Published in Schizophr Res on April 01, 2004
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct (2008) 6.32
Neurocircuitry of mood disorders. Neuropsychopharmacology (2010) 5.57
A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res (2005) 4.34
The subgenual anterior cingulate cortex in mood disorders. CNS Spectr (2008) 3.40
The brain reward circuitry in mood disorders. Nat Rev Neurosci (2013) 3.08
DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage (2005) 2.84
Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev (2009) 2.44
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry (2008) 2.42
Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26
Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc Natl Acad Sci U S A (2008) 2.25
A molecular signature of depression in the amygdala. Am J Psychiatry (2009) 2.18
A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics (2013) 1.97
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci (2008) 1.96
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology (2010) 1.81
Functional and structural connectivity between the perigenual anterior cingulate and amygdala in bipolar disorder. Biol Psychiatry (2009) 1.59
Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr Bull (2007) 1.59
eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia? Schizophr Bull (2007) 1.57
A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev (2009) 1.49
Neuroinflammation and psychiatric illness. J Neuroinflammation (2013) 1.42
Fronto-temporal disconnectivity in schizotypal personality disorder: a diffusion tensor imaging study. Biol Psychiatry (2005) 1.41
Age-related deficits in fronto-temporal connections in schizophrenia: a diffusion tensor imaging study. Schizophr Res (2008) 1.38
Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev (2010) 1.38
Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol (2010) 1.36
The stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology (2010) 1.30
Alterations in white matter evident before the onset of psychosis. Schizophr Bull (2012) 1.29
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol (2009) 1.28
Association between SNPs and gene expression in multiple regions of the human brain. Transl Psychiatry (2012) 1.27
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci U S A (2006) 1.25
Bipolar disorder: from genes to behavior pathways. J Clin Invest (2009) 1.24
Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci (2009) 1.23
Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry (2011) 1.23
From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry (2013) 1.21
Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression. Biol Psychiatry (2012) 1.21
Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr Bull (2010) 1.21
Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophr Bull (2008) 1.21
Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr Res (2007) 1.19
Extensive white matter abnormalities in patients with first-episode schizophrenia: a Diffusion Tensor Iimaging (DTI) study. Schizophr Res (2013) 1.19
Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum. Schizophr Res (2008) 1.16
Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression. Biol Psychiatry (2012) 1.14
Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Ann Gen Psychiatry (2006) 1.13
Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry (2012) 1.13
Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry (2007) 1.12
Thalamo-frontal white matter alterations in chronic schizophrenia: a quantitative diffusion tractography study. Hum Brain Mapp (2009) 1.12
In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res (2009) 1.12
Abnormal anterior cingulum integrity in bipolar disorder determined through diffusion tensor imaging. Br J Psychiatry (2008) 1.11
Lower orbital frontal white matter integrity in adolescents with bipolar I disorder. J Am Acad Child Adolesc Psychiatry (2009) 1.10
Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry (2005) 1.10
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology? Schizophr Res (2014) 1.06
A voxel-based diffusion tensor imaging study of white matter in bipolar disorder. Neuropsychopharmacology (2009) 1.06
Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment (2011) 1.06
Whiter matter abnormalities in medication-naive subjects with a single short-duration episode of major depressive disorder. Psychiatry Res (2010) 1.05
White matter 'potholes' in early-onset schizophrenia: a new approach to evaluate white matter microstructure using diffusion tensor imaging. Psychiatry Res (2009) 1.05
Extracellular matrix abnormalities in schizophrenia. Neuropharmacology (2011) 1.04
Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging (2008) 1.03
A putative functional role for oligodendrocytes in mood regulation. Transl Psychiatry (2012) 1.02
White matter alterations in deficit schizophrenia. Neuropsychopharmacology (2008) 1.02
A Ventral Prefrontal-Amygdala Neural System in Bipolar Disorder: A View from Neuroimaging Research. Acta Neuropsychiatr (2009) 1.01
Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am J Psychiatry (2007) 1.01
Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia. Schizophr Res (2012) 1.01
Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology (2012) 1.00
White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia. Schizophr Res (2013) 1.00
Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex. Front Neuroanat (2009) 0.99
Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory. Schizophr Res (2011) 0.99
White matter microstructure in untreated first episode bipolar disorder with psychosis: comparison with schizophrenia. Bipolar Disord (2011) 0.95
Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia. Schizophr Bull (2015) 0.95
Serum S100B represents a new biomarker for mood disorders. Curr Drug Targets (2013) 0.94
Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res (2007) 0.94
Impaired interhemispheric connectivity in medication-naive patients with major depressive disorder. J Psychiatry Neurosci (2013) 0.94
The impact of vascular burden on late-life depression. Brain Res Rev (2009) 0.94
Integrated neurobiology of bipolar disorder. Front Psychiatry (2014) 0.93
Functional neuroanatomy of bipolar disorder: structure, function, and connectivity in an amygdala-anterior paralimbic neural system. Bipolar Disord (2012) 0.93
Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol (2010) 0.93
Mapping corticocortical structural integrity in schizophrenia and effects of genetic liability. Biol Psychiatry (2011) 0.93
What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia. Front Integr Neurosci (2013) 0.92
Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders. Front Neurosci (2010) 0.92
Pathway analyses implicate glial cells in schizophrenia. PLoS One (2014) 0.90
Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss. Neuroimage (2009) 0.90
Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. Schizophr Bull (2014) 0.88
Accelerated white matter aging in schizophrenia: role of white matter blood perfusion. Neurobiol Aging (2014) 0.88
Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology (2012) 0.88
Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev Neurosci (2013) 0.87
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatr Scand (2012) 0.87
Neuropathological changes in the nucleus basalis in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2012) 0.86
Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes. Schizophr Res (2011) 0.86
Maternal infection and white matter toxicity. Neurotoxicology (2006) 0.86
Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. Schizophr Res (2013) 0.86
BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. Adolesc Psychiatry (2005) 0.86
Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
Microstructural white matter changes in the corpus callosum of young people with Bipolar Disorder: a diffusion tensor imaging study. PLoS One (2013) 0.85
Alcohol dependence-related increase of glial cell density in the anterior cingulate cortex of suicide completers. J Psychiatry Neurosci (2009) 0.85
Role of NG2 expressing cells in addiction: a new approach for an old problem. Front Pharmacol (2014) 0.85
DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PLoS One (2014) 0.84
Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy study. Psychiatry Res (2010) 0.84
Resilient emotionality and molecular compensation in mice lacking the oligodendrocyte-specific gene Cnp1. Transl Psychiatry (2011) 0.84
Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders. Schizophr Res Treatment (2011) 0.84
Biological substrates underpinning diagnosis of major depression. Int J Neuropsychopharmacol (2013) 0.84
Synchrony in schizophrenia: a window into circuit-level pathophysiology. Curr Opin Neurobiol (2014) 0.83
Neuropathological analysis of lacunes and microvascular lesions in late-onset depression. Neuropathol Appl Neurobiol (2010) 0.83
Roles of white matter in central nervous system pathophysiologies. ASN Neuro (2012) 0.83
Microstructural abnormalities of white matter differentiate pediatric and adult-onset bipolar disorder. Bipolar Disord (2012) 0.83
Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse (2005) 1.30
Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res (2007) 1.25
The role of oligodendrocyte pathology in schizophrenia. Int J Neuropsychopharmacol (2007) 1.24
Decreased numerical density of CA3 hippocampal mossy fiber synapses in schizophrenia. Synapse (2007) 1.12
Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment (2011) 1.06
Ultrastructural damage of capillaries in the neocortex in schizophrenia. World J Biol Psychiatry (2010) 0.90